Tobramycin profile:
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Buch |
Sprache: | English |
Veröffentlicht: |
Weinheim u.a.
VCH
1988
|
Schriftenreihe: | Mitteilung der Kommission für Klinisch-Toxikologische Analytik / Deutsche Forschungsgemeinschaft / Kommission für Klinisch-Toxikologische Analytik
9 |
Schlagworte: | |
Beschreibung: | VIII, 30 S. |
ISBN: | 3527273700 0895738708 |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV001328606 | ||
003 | DE-604 | ||
005 | 20011206 | ||
007 | t | ||
008 | 890620s1988 |||| 00||| eng d | ||
020 | |a 3527273700 |9 3-527-27370-0 | ||
020 | |a 0895738708 |9 0-89573-870-8 | ||
035 | |a (OCoLC)18523312 | ||
035 | |a (DE-599)BVBBV001328606 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | 0 | |a eng | |
049 | |a DE-12 |a DE-703 |a DE-355 |a DE-29 |a DE-210 |a DE-83 |a DE-706 | ||
050 | 0 | |a RM666.G44 | |
082 | 0 | |a 615/.32992 |2 19 | |
084 | |a VS 8720 |0 (DE-625)147720:253 |2 rvk | ||
084 | |a XI 3403 |0 (DE-625)152996:12909 |2 rvk | ||
084 | |a MED 923f |2 stub | ||
084 | |a CHE 875f |2 stub | ||
084 | |a MED 335f |2 stub | ||
100 | 1 | |a Maes, Robert A. A. |e Verfasser |4 aut | |
245 | 1 | 0 | |a Tobramycin profile |c comp. by Robert A. A. Maes and Michael Oellerich |
264 | 1 | |a Weinheim u.a. |b VCH |c 1988 | |
300 | |a VIII, 30 S. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 1 | |a Mitteilung der Kommission für Klinisch-Toxikologische Analytik / Deutsche Forschungsgemeinschaft / Kommission für Klinisch-Toxikologische Analytik |v 9 | |
650 | 4 | |a Gentamicin | |
650 | 4 | |a Tobramycin | |
650 | 0 | 7 | |a Toxikologie |0 (DE-588)4060538-3 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Toxikologische Analyse |0 (DE-588)4078371-6 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Pharmakologie |0 (DE-588)4045687-0 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Tobramycin |0 (DE-588)4185587-5 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Physiologie |0 (DE-588)4045981-0 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Antibiotikum |0 (DE-588)4002257-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Arzneimittel |0 (DE-588)4003115-9 |2 gnd |9 rswk-swf |
689 | 0 | 0 | |a Tobramycin |0 (DE-588)4185587-5 |D s |
689 | 0 | 1 | |a Toxikologische Analyse |0 (DE-588)4078371-6 |D s |
689 | 0 | |5 DE-604 | |
689 | 1 | 0 | |a Tobramycin |0 (DE-588)4185587-5 |D s |
689 | 1 | 1 | |a Toxikologie |0 (DE-588)4060538-3 |D s |
689 | 1 | |5 DE-604 | |
689 | 2 | 0 | |a Tobramycin |0 (DE-588)4185587-5 |D s |
689 | 2 | 1 | |a Pharmakologie |0 (DE-588)4045687-0 |D s |
689 | 2 | |5 DE-604 | |
689 | 3 | 0 | |a Antibiotikum |0 (DE-588)4002257-2 |D s |
689 | 3 | |8 1\p |5 DE-604 | |
689 | 4 | 0 | |a Arzneimittel |0 (DE-588)4003115-9 |D s |
689 | 4 | |8 2\p |5 DE-604 | |
689 | 5 | 0 | |a Physiologie |0 (DE-588)4045981-0 |D s |
689 | 5 | |8 3\p |5 DE-604 | |
700 | 1 | |a Oellerich, Michael |e Verfasser |4 aut | |
810 | 2 | |a Deutsche Forschungsgemeinschaft / Kommission für Klinisch-Toxikologische Analytik |t Mitteilung der Kommission für Klinisch-Toxikologische Analytik |v 9 |w (DE-604)BV000002460 |9 9 | |
999 | |a oai:aleph.bib-bvb.de:BVB01-000802954 | ||
883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
883 | 1 | |8 3\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk |
Datensatz im Suchindex
_version_ | 1804115735861002240 |
---|---|
any_adam_object | |
author | Maes, Robert A. A. Oellerich, Michael |
author_facet | Maes, Robert A. A. Oellerich, Michael |
author_role | aut aut |
author_sort | Maes, Robert A. A. |
author_variant | r a a m raa raam m o mo |
building | Verbundindex |
bvnumber | BV001328606 |
callnumber-first | R - Medicine |
callnumber-label | RM666 |
callnumber-raw | RM666.G44 |
callnumber-search | RM666.G44 |
callnumber-sort | RM 3666 G44 |
callnumber-subject | RM - Therapeutics and Pharmacology |
classification_rvk | VS 8720 XI 3403 |
classification_tum | MED 923f CHE 875f MED 335f |
ctrlnum | (OCoLC)18523312 (DE-599)BVBBV001328606 |
dewey-full | 615/.32992 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 615 - Pharmacology and therapeutics |
dewey-raw | 615/.32992 |
dewey-search | 615/.32992 |
dewey-sort | 3615 532992 |
dewey-tens | 610 - Medicine and health |
discipline | Chemie / Pharmazie Chemie Medizin |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02828nam a2200709 cb4500</leader><controlfield tag="001">BV001328606</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20011206 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">890620s1988 |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3527273700</subfield><subfield code="9">3-527-27370-0</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0895738708</subfield><subfield code="9">0-89573-870-8</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)18523312</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV001328606</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-703</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-210</subfield><subfield code="a">DE-83</subfield><subfield code="a">DE-706</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM666.G44</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.32992</subfield><subfield code="2">19</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VS 8720</subfield><subfield code="0">(DE-625)147720:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 3403</subfield><subfield code="0">(DE-625)152996:12909</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">MED 923f</subfield><subfield code="2">stub</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">CHE 875f</subfield><subfield code="2">stub</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">MED 335f</subfield><subfield code="2">stub</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Maes, Robert A. A.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Tobramycin profile</subfield><subfield code="c">comp. by Robert A. A. Maes and Michael Oellerich</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Weinheim u.a.</subfield><subfield code="b">VCH</subfield><subfield code="c">1988</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">VIII, 30 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Mitteilung der Kommission für Klinisch-Toxikologische Analytik / Deutsche Forschungsgemeinschaft / Kommission für Klinisch-Toxikologische Analytik</subfield><subfield code="v">9</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Gentamicin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tobramycin</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Toxikologie</subfield><subfield code="0">(DE-588)4060538-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Toxikologische Analyse</subfield><subfield code="0">(DE-588)4078371-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Tobramycin</subfield><subfield code="0">(DE-588)4185587-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Physiologie</subfield><subfield code="0">(DE-588)4045981-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Antibiotikum</subfield><subfield code="0">(DE-588)4002257-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Tobramycin</subfield><subfield code="0">(DE-588)4185587-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Toxikologische Analyse</subfield><subfield code="0">(DE-588)4078371-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Tobramycin</subfield><subfield code="0">(DE-588)4185587-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Toxikologie</subfield><subfield code="0">(DE-588)4060538-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Tobramycin</subfield><subfield code="0">(DE-588)4185587-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="3" ind2="0"><subfield code="a">Antibiotikum</subfield><subfield code="0">(DE-588)4002257-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="4" ind2="0"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="4" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="5" ind2="0"><subfield code="a">Physiologie</subfield><subfield code="0">(DE-588)4045981-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="5" ind2=" "><subfield code="8">3\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Oellerich, Michael</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="810" ind1="2" ind2=" "><subfield code="a">Deutsche Forschungsgemeinschaft / Kommission für Klinisch-Toxikologische Analytik</subfield><subfield code="t">Mitteilung der Kommission für Klinisch-Toxikologische Analytik</subfield><subfield code="v">9</subfield><subfield code="w">(DE-604)BV000002460</subfield><subfield code="9">9</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-000802954</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield></record></collection> |
id | DE-604.BV001328606 |
illustrated | Not Illustrated |
indexdate | 2024-07-09T15:27:21Z |
institution | BVB |
isbn | 3527273700 0895738708 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-000802954 |
oclc_num | 18523312 |
open_access_boolean | |
owner | DE-12 DE-703 DE-355 DE-BY-UBR DE-29 DE-210 DE-83 DE-706 |
owner_facet | DE-12 DE-703 DE-355 DE-BY-UBR DE-29 DE-210 DE-83 DE-706 |
physical | VIII, 30 S. |
publishDate | 1988 |
publishDateSearch | 1988 |
publishDateSort | 1988 |
publisher | VCH |
record_format | marc |
series2 | Mitteilung der Kommission für Klinisch-Toxikologische Analytik / Deutsche Forschungsgemeinschaft / Kommission für Klinisch-Toxikologische Analytik |
spelling | Maes, Robert A. A. Verfasser aut Tobramycin profile comp. by Robert A. A. Maes and Michael Oellerich Weinheim u.a. VCH 1988 VIII, 30 S. txt rdacontent n rdamedia nc rdacarrier Mitteilung der Kommission für Klinisch-Toxikologische Analytik / Deutsche Forschungsgemeinschaft / Kommission für Klinisch-Toxikologische Analytik 9 Gentamicin Tobramycin Toxikologie (DE-588)4060538-3 gnd rswk-swf Toxikologische Analyse (DE-588)4078371-6 gnd rswk-swf Pharmakologie (DE-588)4045687-0 gnd rswk-swf Tobramycin (DE-588)4185587-5 gnd rswk-swf Physiologie (DE-588)4045981-0 gnd rswk-swf Antibiotikum (DE-588)4002257-2 gnd rswk-swf Arzneimittel (DE-588)4003115-9 gnd rswk-swf Tobramycin (DE-588)4185587-5 s Toxikologische Analyse (DE-588)4078371-6 s DE-604 Toxikologie (DE-588)4060538-3 s Pharmakologie (DE-588)4045687-0 s Antibiotikum (DE-588)4002257-2 s 1\p DE-604 Arzneimittel (DE-588)4003115-9 s 2\p DE-604 Physiologie (DE-588)4045981-0 s 3\p DE-604 Oellerich, Michael Verfasser aut Deutsche Forschungsgemeinschaft / Kommission für Klinisch-Toxikologische Analytik Mitteilung der Kommission für Klinisch-Toxikologische Analytik 9 (DE-604)BV000002460 9 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 3\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
spellingShingle | Maes, Robert A. A. Oellerich, Michael Tobramycin profile Gentamicin Tobramycin Toxikologie (DE-588)4060538-3 gnd Toxikologische Analyse (DE-588)4078371-6 gnd Pharmakologie (DE-588)4045687-0 gnd Tobramycin (DE-588)4185587-5 gnd Physiologie (DE-588)4045981-0 gnd Antibiotikum (DE-588)4002257-2 gnd Arzneimittel (DE-588)4003115-9 gnd |
subject_GND | (DE-588)4060538-3 (DE-588)4078371-6 (DE-588)4045687-0 (DE-588)4185587-5 (DE-588)4045981-0 (DE-588)4002257-2 (DE-588)4003115-9 |
title | Tobramycin profile |
title_auth | Tobramycin profile |
title_exact_search | Tobramycin profile |
title_full | Tobramycin profile comp. by Robert A. A. Maes and Michael Oellerich |
title_fullStr | Tobramycin profile comp. by Robert A. A. Maes and Michael Oellerich |
title_full_unstemmed | Tobramycin profile comp. by Robert A. A. Maes and Michael Oellerich |
title_short | Tobramycin profile |
title_sort | tobramycin profile |
topic | Gentamicin Tobramycin Toxikologie (DE-588)4060538-3 gnd Toxikologische Analyse (DE-588)4078371-6 gnd Pharmakologie (DE-588)4045687-0 gnd Tobramycin (DE-588)4185587-5 gnd Physiologie (DE-588)4045981-0 gnd Antibiotikum (DE-588)4002257-2 gnd Arzneimittel (DE-588)4003115-9 gnd |
topic_facet | Gentamicin Tobramycin Toxikologie Toxikologische Analyse Pharmakologie Physiologie Antibiotikum Arzneimittel |
volume_link | (DE-604)BV000002460 |
work_keys_str_mv | AT maesrobertaa tobramycinprofile AT oellerichmichael tobramycinprofile |